title: [Subclinical hypercortisolism in incidentally detected adrenal adenoma].
abstract: OBJECTIVE
  To define in a prospective study the prevalence and manifestations of subclinical hypercortisolism in a sizeable group of patients with incidentally detected adrenal adenoma. Such tumour - although usually clinically silent - may cause discrete endocrine dysfunctions.
  
  
  METHODS
  Between 1990 and 1994, 85 consecutive patients with incidentally discovered adrenal adenoma were investigated (54 women, 31 men; mean age 54.1 +/- 13 [24-81] years). In addition to history and clinical examination all patients had a low-dose dexamethasone suppression test (2mg) and their morning basal plasma ACTH concentration was measured. The diagnosis of subclinical hypercortisolism was made if there was inadequate suppression of cortisol after dexamethasone administration, plasma ACTH level was decreased and there were no clinical signs of Cushing's syndrome.
  
  
  RESULTS
  Five of the patients fulfilled the criteria of subclinical hypercortisolism (prevalence of 6%). One of them had oligomenorrhoea, another arterial hypertension, and three had mild histological proof of adrenal adenoma. Postoperatively the patient with oligomenorrhoea had normal menstrual cycles, while in all others with subclinical hypercortisolism excision of the tumour had no influence of their clinical state.
  
  
  CONCLUSIONS
  Subclinical hypercortisolism is rare, but is one of the most common endocrine disorders in patients with incidental adrenal adenoma. It can be diagnosed only by hormonal analysis. Once the latent cortisol excess has been eliminated, those symptoms which are due to hormonal abnormality may regress, but nonspecific signs, such as obesity or hypertension, may not necessarily improve.
authors.affiliation: Abteilung Endokrinologie und Rheumatologie, Medizinische Klinik und Poliklinik, Universität Düsseldorf.
authors.forename: T
authors.initials: T
authors.lastname: Seppel
authors.forename: R
authors.initials: R
authors.lastname: Schlaghecke
mesh_terms: D000236:Adenoma / Q000150:complications / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D000308:Adrenocortical Hyperfunction / Q000097:blood / Q000209:etiology*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000150:complications / Q000175:diagnosis; D003907:Dexamethasone; D003937:Diagnosis, Differential; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D018209:Myelolipoma / Q000150:complications / Q000175:diagnosis; D010673:Pheochromocytoma / Q000150:complications / Q000175:diagnosis; D011446:Prospective Studies
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone